Kangmei Pharma | 600518 - Eigenkapital Und Reserven

Aktienkurs
1.65
Täglich Wechseln
-0.04 -2.37%
Monatlich
-6.78%
Jährlich
-15.82%
Q2 Prognose
1.67




Eigenkapital Und Reserven Veränderung Datum
Akebia Therapeutics USD 27.38M 5.24M 2026-03
Alaunos Therapeutics USD 2.15M 650K 2025-12
Avita Medical AUD -16.65M 3.76M 2025-12
Cspc Pharmaceutical CNY 33.18B 71.46M 2025-12
Dianthus Therapeutics USD 1.2B 707.91M 2026-03
Genomma Lab Internacional MXN 11.72B 603.74M 2026-03
Hypermarcas BRL 12.52B 266.92M 2025-12
Ionis Pharmaceuticals USD 491.41M 2.32M 2026-03
IQVIA Holdings USD 6.22B 282M 2026-03
Jiangsu Hengrui CNY 63.63B 2.35B 2026-03
Kangmei Pharma CNY 7.22B 504.3M 2025-09
Moderna USD 7.41B 1.24B 2026-03
Organon & Co USD 903M 151M 2026-03
Revvity USD 7.25B 125.54M 2025-12
Sh Fosun Pharma CNY 49.15B 248.15M 2026-03
Tectonic Therapeutic USD 230.42M 20.91M 2026-03
Viatris USD 14.66B 53.6M 2026-03
Wuxi Apptec CNY 84.77B 4.11B 2026-03
Xeris Pharmaceuticals USD 13.01M 678K 2026-03
Zz Pientze Pharmaceu CNY 15.21B 740.32M 2026-03